Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study
- PMID: 28012282
- PMCID: PMC5553766
- DOI: 10.1900/RDS.2016.13.187
Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study
Abstract
Objectives: To evaluate the ability of low-level fasting high-density lipoprotein cholesterol (HDLC) to predict the incidence of type 2 diabetes (T2D) in an Iranian high-risk population.
Methods: Seven-year follow-up data (n = 1,775) in non-diabetic first-degree relatives (FDR) of consecutive patients with T2D aged 30-70 years were analyzed. The primary outcome was the diagnosis of T2D based on repeated oral glucose tolerance test (OGTT). We used Cox proportional hazard models to estimate the hazard ratio (HR) for the incidence of T2D across quartiles of HDLC, and plotted a receiver operating characteristic (ROC) curve to assess discrimination.
Results: The highest quartile compared with the lowest quartile of HDLC was associated with T2D in age- and gender-adjusted models (HR: 0.83, 95% CI: 0.73-0.95). Further adjustment for fasting plasma glucose and cholesterol attenuated the association for T2D incidence (HR: 0.93, 95% CI: 0.80-1.08). The area under the ROC curve for HDLC was 54.1% (95% CI: 50.2-58.0).
Conclusions: HDLC level was a weak predictor of T2D in an Iranian high-risk population, independent of age and gender.
Figures


Similar articles
-
Utility of serum lipid ratios for predicting incident type 2 diabetes: the Isfahan Diabetes Prevention Study.Diabetes Metab Res Rev. 2016 Sep;32(6):572-80. doi: 10.1002/dmrr.2770. Epub 2016 Jan 26. Diabetes Metab Res Rev. 2016. PMID: 26663847
-
Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan diabetes prevention study.Diabetes Metab Syndr. 2018 Sep;12(5):715-719. doi: 10.1016/j.dsx.2018.04.019. Epub 2018 Apr 21. Diabetes Metab Syndr. 2018. PMID: 29699950
-
Low-density lipoprotein cholesterol and metabolic syndrome in an Iranian high-risk population.Diabetes Metab Syndr. 2015 Apr-Jun;9(2):91-7. doi: 10.1016/j.dsx.2014.07.003. Epub 2014 Aug 6. Diabetes Metab Syndr. 2015. PMID: 25108602
-
The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction.Acta Diabetol. 2015 Aug;52(4):781-8. doi: 10.1007/s00592-014-0709-5. Epub 2015 Jan 10. Acta Diabetol. 2015. PMID: 25572334
-
High-density lipoprotein cholesterol and carcinogenesis.Trends Endocrinol Metab. 2023 May;34(5):303-313. doi: 10.1016/j.tem.2023.02.009. Epub 2023 Mar 25. Trends Endocrinol Metab. 2023. PMID: 36973155 Review.
Cited by
-
The association of ALT to HDL-C ratio with type 2 diabetes in 50-74 years old adults: a population-based study.Sci Rep. 2024 Apr 24;14(1):9390. doi: 10.1038/s41598-024-60092-9. Sci Rep. 2024. PMID: 38658745 Free PMC article.
-
Patterns of changes in serum lipid profiles in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.Lipids Health Dis. 2020 Aug 23;19(1):193. doi: 10.1186/s12944-020-01371-y. Lipids Health Dis. 2020. PMID: 32829710 Free PMC article.
References
-
- Gordon DJ, Probstfield JL, Garrison RJ, Neaton GD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15. - PubMed
-
- Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893–2898. - PubMed
-
- Karadag MK, Akbulut M. Low HDL levels as the most common metabolic syndrome risk factor in heart failure. Int Heart J. 2009;50:571–580. - PubMed
-
- Rahilly-Tierney CR, Spiro A 3rd, Vokonas P, Gaziano JM. Relation between high-density lipoprotein cholesterol and survival to age 85 years in men (from the VA normative aging study) Am J Cardiol. 2011;107:1173–1177. - PubMed
-
- Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ, Sedlis SP, Kostuk W, Spertus GA, Dada M, Chaitman BR, Mancini GB, Weintraub WS. Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: a post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) J Am Coll Cardiol. 2013;62:1826–1833. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical